|Daily Range||$103.34 - $104.14|
|52-Week Range||$85.24 - $107.45|
|Dividend (Yield)||$0.00 (2.4%)|
|Average Daily Volume||34,552|
|Current FY EPS||$7.57|
News & Commentary
Wall Street panicked at the end of 2000 when Abbott Labs announced it was acquiring the pharmaceutical business of BASF. Shares sank 7.1% the next trading day on fears of dilution and a lack of execution. Turns out that was a great buying opportunity.
It’s one of the most popular contamination cleansers in the world; businesses are using it in everything from swimming pools to coal mines.
Germany's investments have grown after a lackluster start to the year, but BASF and Siemens are looking to the long run for gains
California’s new law will have profound implications for consumer goods companies.
Will fish-oil treatment maker Amarin go belly up as generic versions of Lovaza, its primary competitor, are approved ahead of schedule?
A primer on the opportunity presented by biocatalysts.
Europe's been stuck in a rut for years, but economists are optimistic about the region's future growth prospects
Germany's PMI ticks up, but many are doubtful that Europe's largest economy can save the faltering eurozone.
Is the DAX in danger between Europe's debt crisis and Germany's lagging manufacturing?
Pressure will remain on German stocks so long as Europe remains under recessionary storm clouds.